Product Images Flublok Trivalent Northern Hemisphere

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Flublok Trivalent Northern Hemisphere NDC 49281-620 by Sanofi Pasteur Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Principal Display Panel - 0.5 mL Syringe Label - flublok 01

Principal Display Panel - 0.5 mL Syringe Label - flublok 01

This is the information for the Influenza Vaccine Flublok®. It is preservative-free and is intended for intramuscular use as a 0.5 mL single-dose. The manufacturer is Protein Sciences Corp. and the product has a specific NDC code.*

Principal Display Panel - 0.5 mL Syringe Carton - flublok 02

Principal Display Panel - 0.5 mL Syringe Carton - flublok 02

This is a description of the Influenza Vaccine Flublok®. It contains a formulation of recombinant hemagglutinin from specific influenza virus strains and is stored refrigerated between 2°C to 8°C (36°F to 46°F). Each 0.5 mL dose is formulated with 45 mcg of recombinant HA and does not contain preservatives. The vaccine is for intramuscular use for individuals 18 years of age and older, and each package includes 10 single-dose pre-filled syringes. The product should not be frozen, and syringes should be protected from light. The manufacturing information indicates that it is produced by Protein Sciences Corporation and distributed by Sanofi Pasteur Inc.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.